LUPIN:NSE
Lupin Ltd
₹1 949,00
arrow_upward
+0,62%(+12,10) 1D
9 Okt., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUPIN...
Open
₹1 948,00
High
₹1 968,90
Low
₹1 942,00
Mkt. cap
894,80Â mjd
Avg. vol.
747,82Â k
Volume
362,46Â k
Dividend
0,92%
Quarterly dividend
₹4,50
Ex-dividend date
17 Jul. 2026
P/E ratio
15,23
52-wk high
₹2 529,50
52-wk low
₹1 900,00
EPS
₹127,94
Shares outstanding
452,41Â m
No. of employees
26Â k
Open
₹1 948,00
High
₹1 968,90
Low
₹1 942,00
Mkt. cap
894,80Â mjd
Avg. vol.
747,82Â k
Volume
362,46Â k
Dividend
0,92%
Quarterly dividend
₹4,50
Ex-dividend date
17 Jul. 2026
P/E ratio
15,23
52-wk high
₹2 529,50
52-wk low
₹1 900,00
EPS
₹127,94
Shares outstanding
452,41Â m
No. of employees
26Â k
News stories
From web sources and news partners
TipRanks
·
2 dae gelede
Lupin Wins U.S. FDA Nod for Generic Phytonadione Injectable
Profile
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
About Lupin Ltd
CEOVinita D. Gupta
Employees26Â k
Founded1968
HeadquartersMumbai, Maharashtra, Indië
SectorPharmaceutical industry
Websitelupin.com